Reply to Hage et al

Clinical Infectious Diseases

Volumn 50, Issue 1, 2010, Pages 123-124

  Cuellar Rodriguez, J ^a   Avery, R K ^a   Lard, M ^a   Budev, M ^a   Gordon, S M ^a   Shrestha, N K ^a   Van Duin, D ^a   Mawhorter, Steven D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT;

ANTIGEN DETECTION; ENDEMIC DISEASE; HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN; INCIDENCE; LETTER; LUNG TRANSPLANTATION; MORBIDITY; MORTALITY; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

EID: 72049096144     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/649006     Document Type: Letter

References (11)

1. Hage C, Kleiman MB, Wheat LJ. Histoplasmosis in solid organ transplant recipients. Clin Infect Dis 2010; 50:122-123 (in this issue).
2. Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002; 4:148-151 (Pubitemid 35364779)
3. Cuellar-Rodriguez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49:710-716
4. Mandell W, Goldberg DM, Neu HC. Histoplasmosis in patients with the acquired immune deficiency syndrome. Am J Med 1986; 81:974-978
5. Salzman SH, Smith RL, Aranda CP. Histoplasmosis in patients at risk for the acquired immunodeficiency syndrome in a nonendemic setting. Chest 1988; 93:916-921 (Pubitemid 18123535)
6. Norman FF, Martin-Davila P, Fortun J, et al. Imported histoplasmosis: two distinct profiles in travelers and immigrants. J Travel Med 2009; 16:258-262
7. Davies SF, Sarosi GA, Peterson PK, et al. Disseminated histoplasmosis in renal transplant recipients. Am J Surg 1979; 137:686-691 (Pubitemid 9179090)
8. Jain VV, Evans T, Peterson MW. Reactivation histoplasmosis after treatment with anti- tumor necrosis factor-α in a patient from a nonendemic area. Respiratory Med 2006; 100:1291-1293 (Pubitemid 43793058)
9. Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26:753-755
10. Arthurs SK, Eid AJ, Deziel PJ, et al. The impact of invasive fungal diseases on survival after lung transplantation. Clin Transplant 2009 [Epub ahead of print].
11. Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for management of histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807-825